Teradyne Analyst Price Targets

Wall Street analyst price targets and consensus rating for Teradyne (TER).

Price Target Range — 10 Quarters

Analyst Consensus — 12 Analysts

10Buy

2Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$348Upside to Avg. PT-16.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 21, 2026	Baird	Quinn Fredrickson	Downgrade	Outperform→Neutral	$420
Jul 30, 2026	Morgan Stanley	Joseph Moore	PT Raise	Equal-Weight	$387→$397
Jul 30, 2026	Evercore ISI Group	Mark Lipacis	PT Raise	Outperform	$370→$420
Jul 29, 2026	Cantor Fitzgerald	C.J. Muse	Maintained	Overweight	$550
Jul 20, 2026	UBS	Timothy Arcuri	PT Raise	Buy	$440→$500
Jul 6, 2026	Goldman Sachs	James Schneider	PT Raise	Buy	$350→$465
Jun 30, 2026	Susquehanna	Mehdi Hosseini	PT Raise	Positive	$415→$550
Jun 29, 2026	Cantor Fitzgerald	C.J. Muse	PT Raise	Overweight	$400→$550
Jun 23, 2026	B of A Securities	Vivek Arya	PT Raise	Buy	$365→$525
Jun 23, 2026	Baird	Richard Eastman	PT Raise	Outperform	$350→$446
Apr 30, 2026	JP Morgan	Samik Chatterjee	Upgrade	Neutral→Overweight	$400
Apr 30, 2026	Citigroup	Atif Malik	PT Raise	Buy	$325→$400
Apr 30, 2026	Goldman Sachs	James Schneider	PT Raise	Buy	$300→$350
Apr 30, 2026	Evercore ISI Group	Mark Lipacis	PT Cut	Outperform	$430→$370
Apr 28, 2026	Stifel	Brian Chin	PT Raise	Buy	$325→$390
Apr 28, 2026	Evercore ISI Group	Mark Lipacis	PT Raise	Outperform	$320→$430
Apr 21, 2026	UBS	Timothy Arcuri	PT Raise	Buy	$325→$440
Apr 16, 2026	JP Morgan	Samik Chatterjee	PT Raise	Neutral	$315→$400
Apr 9, 2026	Susquehanna	Mehdi Hosseini	PT Raise	Positive	$335→$415
Apr 9, 2026	Cantor Fitzgerald	C.J. Muse	PT Raise	Overweight	$330→$400

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
CNBC Halftime Report Final Trades: UnitedHealth Group, The Goldman Sachs Group, Teradyne

Benzinga Newsdesk

This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed ratings for top stocks. See full list at Benzinga's analyst ratings page. TER, TX and more.

Avi Kapoor

PRO
Baird Downgrades Teradyne to Neutral, Maintains Price Target to $420

Baird analyst Quinn Fredrickson downgrades Teradyne (NASDAQ:TER) from Outperform to Neutral and maintains the price target from $420 to $420.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $397

Morgan Stanley analyst Joseph Moore maintains Teradyne (NASDAQ:TER) with a Equal-Weight and raises the price target from $387 to $397.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Teradyne, Raises Price Target to $420

Evercore ISI Group analyst Mark Lipacis maintains Teradyne (NASDAQ:TER) with a Outperform and raises the price target from $370 to $420.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target

Cantor Fitzgerald analyst C.J. Muse reiterates Teradyne (NASDAQ:TER) with a Overweight and maintains $550 price target.

Benzinga Newsdesk

Teradyne Inc

Teradyne Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
CNBC Halftime Report Final Trades: UnitedHealth Group, The Goldman Sachs Group, Teradyne

This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PRO
Baird Downgrades Teradyne to Neutral, Maintains Price Target to $420

PRO
Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $397

PRO
Evercore ISI Group Maintains Outperform on Teradyne, Raises Price Target to $420

PRO
Cantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target

People Also Watch

People Also Watch

Teradyne Inc

Teradyne Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCNBC Halftime Report Final Trades: UnitedHealth Group, The Goldman Sachs Group, Teradyne

This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PROBaird Downgrades Teradyne to Neutral, Maintains Price Target to $420

PROMorgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $397

PROEvercore ISI Group Maintains Outperform on Teradyne, Raises Price Target to $420

PROCantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target

People Also Watch

People Also Watch

PRO
CNBC Halftime Report Final Trades: UnitedHealth Group, The Goldman Sachs Group, Teradyne

PRO
Baird Downgrades Teradyne to Neutral, Maintains Price Target to $420

PRO
Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $397

PRO
Evercore ISI Group Maintains Outperform on Teradyne, Raises Price Target to $420

PRO
Cantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target